NewAmsterdam Pharma Company
NAMS
#4361
Rank
HK$13.49 B
Marketcap
HK$122.91
Share price
-12.17%
Change (1 day)
-26.67%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : HK$0.83 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's total liabilities are HK$0.83 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NewAmsterdam Pharma Company - Total liabilities on balance sheet (from 2023 to 2023)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$0.83 B81.39%
2023-12-31HK$0.45 B12.95%
2022-12-31HK$0.40 B306.34%
2021-12-31HK$99.89 M-33.5%
2020-12-31HK$0.15 B